| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/RCCM.200710-1458OC |
| P8608 | Fatcat ID | release_pzw3satblrax5lkm6o33huh3tm |
| P698 | PubMed publication ID | 18310479 |
| P5875 | ResearchGate publication ID | 5542877 |
| P2093 | author name string | Christian Heiss | |
| William Grossman | |||
| Yerem Yeghiazarians | |||
| Teresa De Marco | |||
| Dana McGlothlin | |||
| Nicolas Amabile | |||
| Petros Minasi | |||
| Eduardo J Rame | |||
| Wendy May Real | |||
| P2860 | cites work | Clinical classification of pulmonary hypertension. | Q30341846 |
| PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics | Q31825950 | ||
| Endothelial dysfunction in pulmonary hypertension | Q34291213 | ||
| Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension | Q34294101 | ||
| Endothelial cell dynamics and complexity theory | Q34633517 | ||
| Markers of endothelial damage in organ dysfunction and sepsis | Q34633607 | ||
| Cellular and molecular pathobiology of pulmonary arterial hypertension | Q35803229 | ||
| Pulmonary arterial hypertension: the key role of echocardiography | Q36124464 | ||
| Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease | Q36519690 | ||
| Procoagulant microparticles: disrupting the vascular homeostasis equation? | Q36600785 | ||
| Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis | Q37110220 | ||
| Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth | Q40292174 | ||
| Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease | Q40379249 | ||
| Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease | Q40422877 | ||
| Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis | Q40646486 | ||
| Endothelium-derived microparticles impair endothelial function in vitro | Q44836488 | ||
| Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure | Q46726712 | ||
| Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. | Q54062676 | ||
| Pulmonary Arterial Hypertension | Q56388760 | ||
| Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology | Q57824349 | ||
| In Vivo Shear Stress Determines Circulating Levels of Endothelial Microparticles in End-Stage Renal Disease | Q58149207 | ||
| Pulmonary Arterial Hypertension | Q58485998 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hemodynamics | Q1642137 |
| endothelium | Q111140 | ||
| P304 | page(s) | 1268-1275 | |
| P577 | publication date | 2008-02-28 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension | |
| P478 | volume | 177 |
| Q37410202 | A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents |
| Q53569909 | Are endothelial microparticles early markers of pulmonary hypertension? |
| Q45970134 | Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model. |
| Q34203939 | Cellular phenotype switching and microvesicles |
| Q36893365 | Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women |
| Q37293820 | Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence |
| Q48410048 | Circulating endothelial microparticle levels and hemodynamic severity of pulmonary hypertension: is there a role for sleep apnea? |
| Q35212590 | Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers |
| Q39413926 | Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity |
| Q40667685 | Circulating microparticles from diabetic rats impair endothelial function and regulate endothelial protein expression. |
| Q43118263 | Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction |
| Q41528822 | Circulating microparticles in severe pulmonary arterial hypertension increase intercellular adhesion molecule-1 expression selectively in pulmonary artery endothelium |
| Q37610439 | Clinical CVVH model removes endothelium-derived microparticles from circulation |
| Q57767331 | Comparison of Endothelial Biomarkers According to Reversibility of Pulmonary Hypertension Secondary to Congenital Heart Disease |
| Q54442928 | Correlation between brachial artery flow-mediated dilation and endothelial microparticle levels for identifying endothelial dysfunction in children with Kawasaki disease. |
| Q45086457 | Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction. |
| Q85015557 | Differential diagnosis of acute rejection and chronic cyclosporine nephropathy after rat renal transplantation by detection of endothelial microparticles (EMP) |
| Q37539923 | Effect of nitric oxide deficiency on the pulmonary PTHrP system. |
| Q48332248 | Elevated plasma endothelial microparticles in Alzheimer's disease. |
| Q58579190 | Endothelial Extracellular Vesicles in Pulmonary Function and Disease |
| Q91904746 | Endothelial Microparticles and Blood Coagulation Activation in Head and Neck Cancer Patients Undergoing Radiotherapy or Radiochemotherapy |
| Q91904704 | Endothelial Microparticles and Vascular Endothelial Growth Factor in Patients With Head and Neck Cancer Undergoing Radiotherapy or Radiochemotherapy |
| Q50171347 | Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis |
| Q36766005 | Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension |
| Q34033423 | Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea |
| Q37555983 | Endothelial microparticles are increased in congenital heart diseases and contribute to endothelial dysfunction |
| Q28386977 | Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study |
| Q38854487 | Endothelial microparticles: Pathogenic or passive players in endothelial dysfunction in autoimmune rheumatic diseases? |
| Q82668100 | Endothelial microparticles: a universal marker of vascular health? |
| Q38001993 | Endothelial microparticles: missing link in endothelial dysfunction? |
| Q90025734 | Endothelial microvesicles carrying Src-rich cargo impair adherens junction integrity and cytoskeleton homeostasis |
| Q88888819 | Endothelial microvesicles in hypoxic hypoxia diseases |
| Q35124934 | Endotoxin-induced monocytic microparticles have contrasting effects on endothelial inflammatory responses. |
| Q93097260 | Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension |
| Q44284893 | Evaluation of microparticles in whole blood by multicolour flow cytometry assay |
| Q37211166 | Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. |
| Q104136970 | Extracellular Vesicles as Unique Signaling Messengers: Role in Lung Diseases |
| Q37801877 | Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Rito |
| Q97526719 | Extracellular vesicles: novel communicators in lung diseases |
| Q36043165 | Flow Cytometric Quantification of Peripheral Blood Cell β-Adrenergic Receptor Density and Urinary Endothelial Cell-Derived Microparticles in Pulmonary Arterial Hypertension |
| Q37452405 | Genomics of pulmonary arterial hypertension: implications for therapy |
| Q35217383 | Human immunodeficiency virus transgenic rats exhibit pulmonary hypertension |
| Q36265919 | Immuno-analysis of microparticles: probing at the limits of detection. |
| Q37316399 | Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases |
| Q34336698 | Increased CD39 nucleotidase activity on microparticles from patients with idiopathic pulmonary arterial hypertension |
| Q33953737 | Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea. |
| Q53192626 | Increased endothelial microparticles and oxidative stress at extreme altitude. |
| Q84641191 | Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension |
| Q37305448 | Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice |
| Q35746142 | Lectin-Based Characterization of Vascular Cell Microparticle Glycocalyx |
| Q37223428 | Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways |
| Q34026858 | Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles |
| Q33857901 | Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation |
| Q90568852 | Microparticles from Endothelial Cells and Immune Cells in Patients with Takayasu Arteritis |
| Q38118341 | Microparticles in health and disease. |
| Q47964479 | Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease. |
| Q38012180 | Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging |
| Q37981578 | Microvesicles in health and disease. |
| Q37273154 | Microvesicles: potential markers and mediators of endothelial dysfunction |
| Q38077234 | Microvesiculation and disease. |
| Q39201920 | Nonclinical safety biomarkers of drug-induced vascular injury: current status and blueprint for the future |
| Q27023547 | On the origin of microparticles: From "platelet dust" to mediators of intercellular communication |
| Q45324894 | Persistence of circulating endothelial microparticles in COPD despite smoking cessation. |
| Q41700530 | Procoagulant and platelet-derived microvesicle absolute counts determined by flow cytometry correlates with a measurement of their functional capacity |
| Q38801779 | Review of the Association between Splenectomy and Chronic Thromboembolic Pulmonary Hypertension. |
| Q38043896 | Rho GTPases in pulmonary vascular dysfunction |
| Q37784137 | Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis |
| Q37210903 | Role of extracellular vesicles in de novo mineralization: an additional novel mechanism of cardiovascular calcification |
| Q64279410 | Sex differences in the expression of cell adhesion molecules on microvesicles derived from cultured human brain microvascular endothelial cells treated with inflammatory and thrombotic stimuli |
| Q54469933 | Small platelet microparticle levels are increased in pulmonary arterial hypertension. |
| Q33754723 | Soluble platelet-endothelial cell adhesion molecule-1, a biomarker of ventilator-induced lung injury |
| Q36609707 | Specific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women |
| Q51063792 | The LPS-induced increase in circulating microparticles is not affected by vitamin C in humans. |
| Q89941195 | The changing face of pulmonary hypertension diagnosis: a historical perspective on the influence of diagnostics and biomarkers |
| Q38202635 | The role of microparticles in chronic obstructive pulmonary disease |
| Q37641758 | The role of microparticles in the pathogenesis of rheumatic diseases. |
| Q37996827 | Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension |
| Q35038418 | Transfer of human hepatocyte growth factor reduces inflammation and prevents pulmonary arterial remodeling in monocrotaline-induced |
| Q39047723 | UVB-generated Microvesicle Particles: A Novel Pathway by Which a Skin-specific Stimulus Could Exert Systemic Effects. |
| Q37436774 | Update in pulmonary hypertension 2008. |
| Q38150963 | Whole brain radiation-induced vascular cognitive impairment: mechanisms and implications |
Search more.